Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report)’s share price was down 10.9% during trading on Monday . The company traded as low as $1.07 and last traded at $1.10. Approximately 43,240 shares changed hands during mid-day trading, an increase of 235% from the average daily volume of 12,903 shares. The stock had previously closed […]
Form DEF 14A AMARIN CORP PLC\UK streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023Repurchased $40.3 million of common stock and paid off $96.2 million of 2023 convertible notesBURLINGAME, Calif. (BUSINESS WIRE) Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” o.
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023
Repurchased $40.3 million of common stock and paid. | May 9, 2023